Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
12,805,677
Total 13F shares
11,148,640
Share change
+1,662,587
Total reported value
$3,114,479
Put/Call ratio
10%
Price per share
$0.28
Number of holders
44
Value change
+$129,897
Number of buys
25
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13D/G
9.9%
8,000,000
$3,120,000 $0 30 Jun 2025
Bhat Laxminarayan
13D/G
3.8%
3,680,874
$1,877,246 +$34,930 22 Sep 2025
TANG CAPITAL MANAGEMENT LLC
13D/G
4.8%
3,399,975
$1,325,990 -$199,028 30 Jun 2025
683 Capital Management, LLC
13D/G
3%
3,492,500
$1,257,300 -$699,300 31 Dec 2025
Schonfeld Strategic Advisors LLC
13D/G 13F
Company
2.8%
1,314,915
$1,157,125 $0 31 Dec 2024
DIADEMA PARTNERS LP
13F
Company
20%
2,506,921
$924,051 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
15%
1,923,228
$709,671 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
13%
1,711,221
$630,756 30 Sep 2025
13F
Persistent Asset Partners Ltd
13F
Company
4.6%
593,902
$218,912 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4.4%
559,243
$206,173 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
4.1%
524,050
$193,165 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
1.8%
228,131
$84,089 30 Sep 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.7%
216,597
$79,838 30 Sep 2025
13F
SIMPLEX TRADING, LLC
13F
Company
1.3%
172,523
$63,000 30 Sep 2025
13F
EMC Capital Management
13F
Company
1%
128,915
$48,000 30 Sep 2025
13F
STATE STREET CORP
13F
Company
0.99%
126,700
$46,702 30 Sep 2025
13F
XTX Topco Ltd
13F
Company
0.78%
100,398
$37,007 30 Sep 2025
13F
Lido Advisors, LLC
13F
Company
0.78%
99,647
$36,730 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.56%
71,379
$26,310 30 Sep 2025
13F
Cetera Investment Advisers
13F
Company
0.47%
60,000
$22,116 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
0.45%
57,553
$21,214 30 Sep 2025
13F
Focus Partners Wealth
13F
Company
0.41%
53,000
$19,536 30 Sep 2025
13F
Sanctuary Advisors, LLC
13F
Company
0.16%
21,000
$14,178 30 Sep 2025
13F
Larson Financial Group LLC
13F
Company
0.27%
35,000
$12,901 30 Sep 2025
13F
Creative Planning
13F
Company
0.25%
32,107
$11,835 30 Sep 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.22%
28,001
$10,321 30 Sep 2025
13F
Vanguard Personalized Indexing Management, LLC
13F
Company
0.19%
23,916
$8,815 30 Sep 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.18%
22,417
$8,263 30 Sep 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.17%
21,773
$8,026 30 Sep 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.16%
20,261
$7,000 30 Sep 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.12%
15,000
$5,529 30 Sep 2025
13F
NRI Wealth Management LC
13F
Company
0.1%
12,380
$4,563 30 Sep 2025
13F
TD Waterhouse Canada Inc.
13F
Company
0.1%
12,495
$4,525 30 Sep 2025
13F
SG Americas Securities, LLC
13F
Company
0.09%
11,560
$4,000 30 Sep 2025
13F
DRIVE WEALTH MANAGEMENT, LLC
13F
Company
0.08%
10,000
$3,686 30 Sep 2025
13F
INSIGNEO ADVISORY SERVICES, LLC
13F
Company
0.08%
10,000
$3,686 30 Sep 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0.07%
9,299
$3,428 30 Sep 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.05%
7,000
$2,580 30 Sep 2025
13F
SBI Securities Co., Ltd.
13F
Company
0.04%
5,004
$1,844 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.03%
4,120
$1,519 30 Sep 2025
13F
IFP Advisors, Inc
13F
Company
0.03%
4,000
$1,474 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
1,500
$1,000 30 Sep 2025
13F
Activest Wealth Management
13F
Company
0.01%
1,000
$369 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
538
$198 30 Sep 2025
13F
Tradewinds Capital Management, LLC
13F
Company
0%
250
$93 30 Sep 2025
13F
VEDANTA PARTNERS, LLC
3/4/5
10%+ Owner
mixed-class rows
1,127,207
mixed-class rows
08 Sep 2022
Leslie D. Funtleyder
3/4/5
Director
class O/S missing
8,200
18 Dec 2025
Parag Saxena
3/4/5
Director
class O/S missing
8,200
18 Dec 2025
Purav Patel
3/4/5
Director
class O/S missing
8,200
18 Dec 2025
Richard A. Margolin
3/4/5
Director
class O/S missing
8,200
18 Dec 2025

Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q4 2025

As of 31 Dec 2025, REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,148,640 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, STATE STREET CORP, BlackRock, Inc., UBS Group AG, and MORGAN STANLEY. This page lists 44 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
40
Q4 2025 holders
44
Holder diff
4
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.